Catalyst
Slingshot members are tracking this event:
Phase 1/2 data of Selinexor - STOMP trial for Multiple Myeloma
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
KPTI |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 05, 2016
Occurred Source:
http://investors.karyopharm.com/releasedetail.cfm?releaseid=1002778
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1/2 Data, Selinexor, Stomp Trial, Multiple Myeloma